Search Within

Alexander Noor Shoushtari

  1. "Jedd Wolchok"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (23)
  3. Research Letter (2)
Groups
  1. Department of Medicine (49)
  2. GSK Faculty (49)
  3. Hematologic Malignancies, Division of (49)
  4. Melanoma Disease Management Team (49)
  5. Melanoma and Immunotherapeutics Service (49)
  6. Solid Tumor Oncology Division (49)

More Groups

People
  1. Jedd Wolchok (49)
  2. Michael Postow (41)
  3. Paul Chapman (37)
  4. Margaret Callahan (36)
  5. Katherine Panageas (26)
  6. Parisa Momtaz (23)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (7)
  5. 2020 (5)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (4)
  3. Journal for ImmunoTherapy of Cancer (4)
  4. Annals of Surgical Oncology (3)
  5. The Oncologist (3)
  6. Melanoma Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (5)
  3. Oxford University Press (5)
  4. Biomed Central Ltd (4)
  5. Lippincott Williams & Wilkins (3)
  6. Springer (3)

More Publishers

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Pilot study of ONCOS-102 and pembrolizumab: Remodeling of the tumor microenvironment and clinical outcomes in anti-PD-1-resistant advanced melanoma
    Journal Article

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Kuryk, L.; Hansen, T. B.; Jäderberg, M.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Repeat dosing of oncolytic adenovirus ONCOS-102 is associated with enhanced and persistent immune responses and improved systemic activity in anti-PD-1 resistant/refractory (R/R) melanoma
    Meeting Abstract

    Shoushtari, A.; Ottesen, L.; Levitsky, V.; Hansen, T. B.; Hornyak, T.; Olszanski, A.; Nyakas, M.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Pilot trial of arginine deprivation plus nivolumab and ipilimumab in patients with metastatic uveal melanoma
    Journal Article

    Kraehenbuehl, L.; Holland, A.; Armstrong, E.; O'Shea, S.; Mangarin, L.; Chekalil, S.; Johnston, A.; Bomalaski, J. S.; Erinjeri, J. P.; Barker, C. A.; more...
    Cancers (2022)

    Fulltext@MSK | Save